No abstract available
Publication types
-
Clinical Trial
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adjuvants, Immunologic / administration & dosage
-
Adult
-
Atorvastatin
-
Biomarkers / analysis
-
Biomarkers / blood
-
Central Nervous System / drug effects
-
Central Nervous System / enzymology
-
Central Nervous System / physiopathology
-
Drug Interactions / immunology
-
Drug Therapy, Combination
-
Heptanoic Acids / administration & dosage*
-
Heptanoic Acids / adverse effects
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
-
Immunologic Factors / administration & dosage
-
Immunologic Factors / adverse effects
-
Interferon beta-1b
-
Interferon-beta / administration & dosage*
-
Matrix Metalloproteinase 9 / blood
-
Matrix Metalloproteinase 9 / drug effects*
-
Multiple Sclerosis, Relapsing-Remitting / blood
-
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
-
Multiple Sclerosis, Relapsing-Remitting / enzymology*
-
Pyrroles / administration & dosage*
-
Pyrroles / adverse effects
-
Tissue Inhibitor of Metalloproteinase-1 / blood
-
Tissue Inhibitor of Metalloproteinase-1 / drug effects*
-
Treatment Outcome
Substances
-
Adjuvants, Immunologic
-
Biomarkers
-
Heptanoic Acids
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Immunologic Factors
-
Pyrroles
-
Tissue Inhibitor of Metalloproteinase-1
-
Interferon beta-1b
-
Interferon-beta
-
Atorvastatin
-
Matrix Metalloproteinase 9